Lewes, DE -- (SBWIRE) -- 09/13/2013 -- LeadingStockAlerts is a financial marketing firm that specializes in assisting the underserved small cap and micro-cap stock community. Out Today’s Focus is on: Synta Pharmaceuticals Corp. (NASDAQ:SNTA), Dendreon Corporation (NASDAQ:DNDN), Flextronics International Ltd. (NASDAQ:FLEX), DURECT Corporation (NASDAQ:DRRX)
Synta Pharmaceuticals Corp. (NASDAQ:SNTA) opened its shares at the price of $7.24 for the day. Its closing price was $6.56 after losing -2.67% for the day. The company traded with the total volume of 2.94 million shares, while its average trading volume remained 1.22 million shares. The beta of SNTA stands at2.65.
How Should Investors Trade SNTA Now? Don’t Miss out a Special Trend Analysis
Synta Pharmaceuticals Corp., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule drugs for treating severe medical conditions, including cancer and chronic inflammatory diseases.
Dendreon Corporation(NASDAQ:DNDN) percentage change surged 2.31% to close at $3.10 with the total traded volume of 2.90 million shares, and average volume of 5.42 million. The 52 week range of the stock remained $2.69 - $7.22, while its day lowest price was $2.97 and it hit its day highest price at $3.13.
Can DNDN Show a Strong Recovery? Find out in This Research Report
Dendreon Corporation, a biotechnology company, engages in the discovery, development, and commercialization of novel therapeutics to enhance cancer treatment options for patients.
Flextronics International Ltd. (NASDAQ:FLEX) started its trading session with the price of $9.48 and closed at $9.35 by scoring -1.53%. FLEX’s stocks traded with total volume of 2.89 million shares, while the average trading volume remained 5.74 million shares. The beta of FLEX stands at 2.24. Day range of the stock was $9.33 -$9.49.
Should FLEX a Buy or Sell Now? Find Out Here
Flextronics International Ltd. provides design and manufacturing services to original equipment manufacturers (OEMs) worldwide.
DURECT Corporation (NASDAQ:DRRX) ended its day with the gain of +9.84% and closed at the price of $1.34 after opening at $1.27. Stock traded during its last trading session with the total volume of 2.88 million shares, as compared to its average volume of 612,546 shares.
What DRRX’s Charts Are Signaling for Traders? Find Out Here
DURECT Corporation, a specialty pharmaceutical company, develops pharmaceutical systems technologies based on its proprietary drug delivery technology platforms.
LeadingStockAlerts is a financial marketing firm that specializes in assisting the underserved small cap and micro-cap stock community.
Our site has been the clear choice for today’s investors and day-traders. As one of the internet’s premiere financial destinations, we offer the investment community some of the market’s leading emerging opportunities. Using a balanced combination of industry experience and high-tech offerings, this site keeps you ahead of the curve and ahead of the bell.
DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT OR WEBSITE. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice.
The information contained in our report should be viewed as commercial advertisement and is not intended to be investment advice. The report is not provided to any particular individual with a view toward their individual circumstances. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.
Read Full Disclaimer at: http://leadingstockalerts.com/disclaimer/